Literature DB >> 1654202

Clinically effective monoclonal antibody 3F8 mediates nonoxidative lysis of human neuroectodermal tumor cells by polymorphonuclear leukocytes.

B H Kushner1, N K Cheung.   

Abstract

Most studies of antibody-dependent cellular cytotoxicity (ADCC) by polymorphonuclear leukocytes (PMN) have supported oxidative lytic processes. This may be because the studies used nonhuman or nonneoplastic cells that were highly sensitive to reactive oxygen species or were small enough to be phagocytosed by PMN. We therefore investigated whether oxygen radicals participate in PMN cytotoxicity toward human neuroectodermal solid tumor cells sensitized by 3F8, which is an anti-ganglioside GD2 murine IgG3 monoclonal antibody with documented anticancer activity in humans. A 4-h 51Cr release assay was used to assess tumor cell lysis by hydrogen peroxide, superoxide, and hypochlorite. Nine of 11 GD2(+) human melanoma and neuroblastoma cell lines had equal or greater resistance to these oxidants as compared to a GD2(-) human carcinoma line (SKBr1-III) found by others (and confirmed by us) to be significantly more resistant to oxidative lysis than a murine cell line (P388D1) representative of those commonly used in cytotoxicity assays. To facilitate detection of oxidant-mediated lysis, subsequent studies of 3F8-mediated ADCC used GD2(+) targets that were relatively sensitive and others that were relatively resistant to oxygen radicals. Normal PMN and PMN obtained from children with chronic granulomatous disease, which do not generate reactive oxygen species, were equally effective in ADCC. Granulocyte-macrophage colony-stimulating factor, which primes oxidative responses of normal but not of chronic granulomatous disease PMN, enhanced ADCC by both kinds of PMN. During ADCC of 3F8-sensitized targets, with or without granulocyte-macrophage colony-stimulating factor, GD2(-) "innocent bystander" tumor cells (including P388D1) were not lysed, a finding consistent with unimportant extracellular release of cytotoxic mediators. Finally, antioxidant and antimyeloperoxidase moieties did not block ADCC. We conclude that oxidants are not key factors in 3F8-mediated lysis by PMN of human neuroectodermal tumor cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654202

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  Protumor and antitumor functions of neutrophil granulocytes.

Authors:  Sven Brandau; Claudia A Dumitru; Stephan Lang
Journal:  Semin Immunopathol       Date:  2012-09-25       Impact factor: 9.623

Review 2.  Anti-GD2 mAbs and next-generation mAb-based agents for cancer therapy.

Authors:  Zulmarie Perez Horta; Jacob L Goldberg; Paul M Sondel
Journal:  Immunotherapy       Date:  2016-09       Impact factor: 4.196

3.  Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor.

Authors:  Irene Y Cheung; Katharine Hsu; Nai-Kong V Cheung
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

Review 4.  Anti-GD2 immunotherapy for neuroblastoma.

Authors:  Sameer Sait; Shakeel Modak
Journal:  Expert Rev Anticancer Ther       Date:  2017-08-14       Impact factor: 4.512

Review 5.  Immunology and immunotherapy of neuroblastoma.

Authors:  Robert C Seeger
Journal:  Semin Cancer Biol       Date:  2011-09-28       Impact factor: 15.707

Review 6.  Monoclonal antibody-based therapy for neuroblastoma.

Authors:  N K Cheung
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

Review 7.  Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Authors:  Nai-Kong V Cheung; Michael A Dyer
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

Review 8.  Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy.

Authors:  Jingjing Liu; Lacey Gunn; Richard Hansen; Jun Yan
Journal:  Exp Mol Pathol       Date:  2009-01-21       Impact factor: 3.362

9.  Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells.

Authors:  Chun-Yen Tsao; Francesco Sabbatino; Nai-Kong V Cheung; Jeff Chi-Feng Hsu; Vincenzo Villani; Xinhui Wang; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

10.  FMLP- and TNF-stimulated monoclonal Lym-1 antibody-dependent lysis of B lymphoblastoid tumour targets by neutrophils.

Authors:  L Ottonello; P Morone; M Mancini; M Amelotti; P Dapino; F Dallegri
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.